Shook David
Chief Medical Officer
Shook David has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 10, 2026.
On the most recent filing, Shook David is listed as Chief Medical Officer at Lyell Immunopharma, Inc. Inside the rolling window, Shook David reported no open-market purchases and 2 open-market sales totaling $31K in LYEL. The largest disclosed transaction in the window is a sale of 1,977 LYEL shares on Jun 10, 2026, worth $25K.
Companies traded
Other insiders at LYEL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$31K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shook David made?
Shook David has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Shook David trade?
Shook David has filed SEC Form 4 disclosures for 1 company, including LYEL.
When was Shook David's most recent SEC Form 4 filing?
Shook David's most recent SEC Form 4 filing on Tracefour is dated Sep 10, 2026.
What is Shook David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shook David is listed as Chief Medical Officer.
What is Shook David's total buy and sell value in the current window?
Inside the rolling retention window, Shook David bought $0 and sold $31K based on SEC Form 4 filings.
What was Shook David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,977 LYEL shares on 2026-06-10, worth $25K, per SEC Form 4 filings.